Vyvanse Savings Card: How to Pay No More Than $15 for ADHD Medications

The Reality of Vyvanse Pricing in 2026

Vyvanse (lisdexamfetamine dimesylate) has transformed ADHD treatment by offering smooth, extended-release efficacy through its unique prodrug formulation. However, out-of-pocket retail pricing for brand-name Vyvanse often exceeds $360 to $420 per month for uninsured patients or those in high-deductible insurance plans.

How the Official "Pay No More Than $15" Program Works

The manufacturer co-pay assistance program is designed to bridge the gap between insurance copays and total retail cost. Here is how it operates:

• Eligibility: Patients must have commercial or private health insurance that covers Vyvanse. Government insurance plans (Medicare, Medicaid, TRICARE) are ineligible under federal anti-kickback statutes.
• Discount Cap: The card typically covers up to $60–$100 in copay costs per 30-day fill, reducing your out-of-pocket payment to as low as $15.
• Annual Limit: Most savings cards allow up to 12 uses per calendar year before re-enrollment is required.

Brand Vyvanse vs Generic Lisdexamfetamine

With generic lisdexamfetamine now approved and widely available across US pharmacies, patients who do not qualify for the manufacturer card can achieve massive savings by requesting the generic formulation. Generic lisdexamfetamine typically ranges between $60 and $110 per month with pharmacy discount vouchers.